Safety, Eligibility, and Provider-Guided Decision-Making Both tirzepatide and semaglutide carry similar contraindications: personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, pregnancy planning, and certain gastrointestinal conditions
Phase 2 clinical trial data for retatrutide, published in the New England Journal of Medicine in 2023, demonstrated mean weight reductions of approximately 1724% of body weight over 48 weeks, depending on dose results that exceed those seen with currently licensed agents in comparable timeframes
BPC-157 is a synthetic pentadecapeptide (15 amino acids) known as Body Protection Compound, based on a partial sequence found in gastric juice
A premium cocktail therefore has to solve two problems
Extended data beyond 104 weeks is not yet published
It delivers antioxidants to the right areas and is easy to use with other skincare products